iRhythm Technologies Inc (IRTC)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $3.05B
Last updated: Nov 17, 2026 at 4:36 PM ET
iRhythm Technologies Inc (IRTC) Statistics
iRhythm Technologies (IRTC) has a market cap of $3.05B and an enterprise value of $3.31B. Revenue grew 21.56% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 8.43% above the market cap, as debt exceeds cash.
| Market Cap | $3.05B |
|---|---|
| Enterprise Value | $3.31B |
| Latest price (Nov 17, 2026) | $89.67 |
Key Dates
The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.5x and 16.8x.
| P/E Ratio | 73.5x |
|---|---|
| Forward P/E | 96.9x |
| P/S Ratio | 3.5x |
| Forward P/S | 3.4x |
| P/B Ratio | 16.8x |
| P/TBV Ratio | 16.8x |
| P/FCF Ratio | 402.1x |
| P/OCF Ratio | 54.9x |
Enterprise Valuation
Counting debt and cash, the company is valued at 436.9x free cash flow.
| EV / Sales | 3.9x |
|---|---|
| EV / FCF | 436.9x |
Price Statistics
The stock is down 47.51% over 52 weeks and trades 18.83% below its 50-day average.
| Beta (1Y) | 0.51 |
|---|---|
| 52-Week Change | -47.51% |
| 1-Month Change | -18.19% |
| 3-Month Change | -28.12% |
| 6-Month Change | -21.24% |
| 5-Year Change | +75.89% |
| 10-Year Change | +394.47% |
| Total Return (1Y) | -47.51% |
| Total Return (3Y CAGR) | +3.25% |
| Total Return (5Y CAGR) | -2.42% |
| Return vs SPY (1Y) | -58.71% |
| Max Drawdown (1Y) | -54.53% |
| Max Drawdown (3Y) | -54.53% |
| Sharpe Ratio (1Y) | -1.11 |
| Correlation with SPY (1Y) | 0.12 |
| 50-Day Average | $110.47 |
| 200-Day Average | $118.95 |
| 52-Week Range | $82.85 to $192.47 |
| RSI (14 Days) | 34.0 |
| Average Volume (20 Days) | 1.01M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.57x current liabilities, and total debt is 3.68x shareholder equity.
| Current Ratio | 3.57x |
|---|---|
| Quick Ratio | 3.45x |
| Debt / Equity | 3.68x |
| Debt / FCF | 88.32x |
| Interest Coverage | -3.34x |
Returns and Efficiency
Return on invested capital is -5.32% over the last 12 months, against a 5-year average of -19.83%.
| Return on Equity (ROE) | -21.79% |
|---|---|
| Return on Assets (ROA) | -3.54% |
| Return on Invested Capital (ROIC) | -5.32% |
| ROE (5Y Average) | -59.44% |
| ROA (5Y Average) | -18.57% |
| ROIC (5Y Average) | -19.83% |
| Asset Turnover | 0.82x |
| Inventory Turnover | 10.36x |
| Receivables Turnover | 10.33x |
| Cash Conversion Cycle | 45 days |
Scores
IRTC has an Altman Z-Score of 2.09, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.09 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $854.04M over the last 12 months.
| Revenue | $854.04M |
|---|---|
| Revenue Growth (YoY) | +21.56% |
| Gross Profit | $617.11M |
| Operating Income | -$49.00M |
| Pretax Income | -$37.64M |
| Net Income | -$38.59M |
| EBITDA | -$17.31M |
| Reported EPS (TTM) | $1.22 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 16.25% of the $1.09B in total assets.
| Cash and Equivalents | $394.72M |
|---|---|
| Total Debt | $651.86M |
| Net Debt | $257.14M |
| Net Debt Per Share | $7.77 |
| Working Capital | $525.48M |
| Shareholder Equity | $177.11M |
| Book Value Per Share | $5.35 |
| Tangible Book Value | $176.24M |
| Tangible Book Per Share | $5.32 |
| Total Assets | $1.09B |
| Total Liabilities | $914.34M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $48.18M of capital spending, operating cash flow left $7.38M of free cash flow.
| Operating Cash Flow | $55.56M |
|---|---|
| Capital Expenditures | $48.18M |
| Free Cash Flow | $7.38M |
| FCF Per Share | $0.22 |
| Depreciation and Amortization | $26.82M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -5.74%, against a 5-year average of -22.25%.
| Gross Margin | 72.26% |
|---|---|
| Operating Margin | -5.74% |
| Pretax Margin | -4.41% |
| Net Margin | -4.52% |
| EBITDA Margin | -2.03% |
| FCF Margin | 0.86% |
| Gross Margin (5Y Average) | 68.29% |
| Operating Margin (5Y Average) | -22.25% |
| Net Margin (5Y Average) | -21.96% |
Growth
Revenue grew 22.05% a year over 3 years.
| Revenue Growth (3Y CAGR) | +22.05% |
|---|---|
| Revenue Growth (5Y CAGR) | +23.02% |
| Book Value Per Share Growth (2Y CAGR) | -18.17% |
| Tangible Book Per Share Growth (2Y CAGR) | -18.23% |
Dividends and Yields
IRTC does not pay a dividend. Its free cash flow yield is 0.25%.
| Earnings Yield | 1.36% |
|---|---|
| FCF Yield | 0.25% |
| Buyback Yield | -0.26% |
| Shareholder Yield | -0.26% |
Peer Position
Against 9 similar companies, IRTC has the highest P/E and the 8th highest ROIC.
P/E RatioPeer median 23.8x
P/S RatioPeer median 3.6x
ROICPeer median 4.12%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +5.47%
| P/E Ratio | 73.5x vs 23.8x median |
|---|---|
| P/S Ratio | 3.5x vs 3.6x median |
| ROIC | -5.32% vs 4.12% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +21.56% vs +5.47% median |
Analyst Forecast
Consensus estimates put revenue growth at 19.84% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +19.84% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About IRTC
What is IRTC's market cap?
iRhythm Technologies has a market cap of $3.05B. Its enterprise value, which adds debt and subtracts cash, is $3.31B.
What is IRTC's P/E ratio?
iRhythm Technologies has a trailing P/E ratio of 73.5x and a forward P/E of 96.9x.
How many shares of IRTC are outstanding?
iRhythm Technologies has 33.10M shares outstanding. The count is up 2.89% from a year earlier.
Does IRTC pay a dividend?
No. iRhythm Technologies does not pay a dividend.
How much debt does IRTC have?
iRhythm Technologies has $651.86M of total debt and $394.72M of cash and equivalents, a net debt position of $257.14M.
IRTC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors